Skip to main content
OpenTrials

Clinical trial condition

Metastatic Cancer

Explore clinical trials studying Metastatic Cancer. Study availability and eligibility vary by location and protocol.

430 public trials 83 recruiting studies
Refine in advanced search Browse all conditions

Metastatic Cancer trial results

Completed

Imatinib Mesylate in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor

NCT00764595

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +12 more
Locations
  • Aichi Cancer Center Nagoya, Aichi-ken, Japan
  • Aichi Medical University Nagoya, Aichi-ken, Japan
  • Hirosaki University, School of Medicine Hirosaki, Aomori, Japan
  • National Hospital Organization Kure Medical Center Kure, Hiroshima, Japan
View all 36 locations
View Trial Details
Completed

Surgery in Treating Patients With Liver Metastasis From a Gastrointestinal Stromal Tumor

NCT00769782

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +12 more
Locations
  • Aichi Cancer Center Nagoya, Aichi-ken, Japan
  • Aichi Medical University Nagoya, Aichi-ken, Japan
  • Hirosaki University, School of Medicine Hirosaki, Aomori, Japan
  • National Hospital Organization Kure Medical Center Kure, Hiroshima, Japan
View all 37 locations
View Trial Details
Completed

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

NCT00003907

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations
  • Front Range Cancer Specialists Fort Collins, Colorado, United States
  • Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Veterans Affairs Medical Center - Atlanta (Decatur) Decatur, Georgia, United States
View all 37 locations
View Trial Details
Completed

Radiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or Sarcoma

NCT00003308

Conditions
Adenocarcinoma, Adnexal Diseases, Brain Diseases, +54 more
Locations
  • Iowa Methodist Medical Center Des Moines, Iowa, United States
  • Mercy Medical Center Des Moines, Iowa, United States
  • Iowa Lutheran Hospital Des Moines, Iowa, United States
  • CCOP - Kalamazoo Kalamazoo, Michigan, United States
View all 14 locations
View Trial Details
Completed

Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas

NCT03311412

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
Locations
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • NEXT Oncology San Antonio, Texas, United States
  • Princess Margaret Cancer Centre Toronto, Ontario, Canada
View Trial Details

Related conditions